Cargando…

341. Evaluation of Antimicrobial Use and Prescribing Patterns During the COVID-19 Pandemic in Patients Receiving Tocilizumab

BACKGROUND: Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infected patients experience systemic inflammation and respiratory distress, which appears to be associated with increased cytokine release. During the peak of coronavirus disease 2019 (COVID-19), tocilizumab was used to treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Barsoum, Barbara, Chang, Kai-Ming, Mulvey, Nicole, Donaghy, Henry, Doan, Thien-Ly
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643850/
http://dx.doi.org/10.1093/ofid/ofab466.542

Ejemplares similares